Navigation Links
Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1%
Date:8/12/2008

cost to the patient).

1Matheson R, Kempers S, Breneman D, et al. Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects. J Drugs Dermatol. 2008; 7:266-271.
2 http://www.niams.nih.gov/Health_Info/Atopic_Dermatitis/default.asp#link_b
3 Fowler JF Jr. Hydrocortisone butyrate 0.1% cream in the treatment of chronic dermatitis. Cutis 2005; 75:125-131.

For more information on Locoid® Lotion for adult to pediatric patients with atopic dermatitis, please contact Peter Volk or Aleen Hosdaghian of Triax Pharmaceuticals, LLC, 908.372.0500.
See www.locoid.com for full prescribing information.

# # #

Read the full story at http://www.prweb.com/releases/2008/08/prweb1190714.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid  Lotion 0.1% 
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Ticket Down is a reputable source of ... Haiti and the United States vs. Honduras at the Toyota Stadium. , The ... July 7th at Toyota Stadium. The tournament, being held on American soil, will kick off ...
(Date:7/7/2015)... ... 2015 , ... Greatist today announced the acquisition of Blood, ... the most fun activities to do with friends. , The acquisition of BSC strengthens ... opportunity for events, e-commerce, and brand partnerships. , “I’ve been a huge fan of ...
(Date:7/7/2015)... , ... July 07, 2015 ... ... leading global provider of advanced delivery technologies and development solutions for drugs, ... exclusive licensing agreement with Excelimmune, Inc. to access its antibody combination therapy ...
(Date:7/7/2015)... ... 2015 , ... Healthpointe is proud to announce the addition of ... pain management specialist, will be evaluating and treating patients with orthopedic complaints, such as ... his Bachelor of Science in Biology from the University of the East, Manila, Dr. ...
(Date:7/7/2015)... ... July 07, 2015 , ... Georgia Partnership for ... communities throughout Georgia, announces the launch of the first ambulance telemedicine program in ... County, GA. The new program will not only provide more immediate patient care, ...
Breaking Medicine News(10 mins):Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2
... from hot flushes in women who are being ... breast cancer, according to new research presented today ... (EBCC-6) in Berlin. , Mrs Jill Hervik, a ... (Tnsberg, Norway), told a news briefing that breast ...
... Union taking immediate legal steps to,dismiss temporary ... WASHINGTON, April 17 The Service ... file a motion to,dismiss the temporary restraining ... against SEIU President Andy Stern and SEIU., ...
... first showing the cancer may have an Achilles, heel, report ... drug Gleevec has forced metastatic melanoma into remission for the ... Boston. , The case involves a 79-year-old woman with melanoma ... carried an abnormality in a gene called KIT, so the ...
... Va., April 17 The American,Chemistry Council (ACC) ... von,Eschenbach requesting FDA to update its review of ... The extensive body of scientific study regarding ... recent media reports have,raised concerns about the safety ...
... to Researchers World-Wide, NEW YORK, April 17 ... award nearly $7 million to,researchers around the world. "The ... National Minority Health Month, that with our 2008 class ... projects, and committed,more than $50 million to research, since ...
... Young Innovations,Inc. (Nasdaq: YDNT ) today announced that ... live and on-demand web cast conference call,on Thursday, April ... audio,broadcast of the call will be available through InterCall ... also be available through the Company,s website, http://www.ydnt.com ...
Cached Medicine News:Health News:Acupuncture relieves hot flushes in breast cancer patients taking tamoxifen 2Health News:SEIU to File Motion to Dismiss CNA Restraining Order 2Health News:Gleevec Pushes Advanced Melanoma Into Remission 2Health News:ACC Calls on FDA to Update Review of Bisphenol A 2Health News:ACC Calls on FDA to Update Review of Bisphenol A 3Health News:The Alliance for Lupus Research Announces 2008 Grantees 2Health News:Young Innovations, Inc. Provides First Quarter Conference Call Details 2
(Date:7/7/2015)... -- Berger & Montague, P.C., a full-spectrum class ... one of the largest and most successful whistleblower ... Faruqi, LLP in settling three separate but related ... Cephalon, Inc., and Biogen, Inc., for a total ... agreements, AstraZeneca will pay the largest sum, $46.5 ...
(Date:7/7/2015)... July 7, 2015 A power morcellator lawsuit ... been settled for an undisclosed amount, Bernstein Liebhard LLP ... in March 2014 in the U.S. District Court, Eastern ... of a widower whose wife had died in February ... hysterectomy that involved the use of a power morcellator. ...
(Date:7/7/2015)... Juli 2015 Sequent Medical, ein ... Entwicklung innovativer Geräte für die Behandlung neurovaskulärer ... von R. Michael Kleine in den ... verfügt über eine mehr als 25-jährige Erfahrung ... hat verschiedene globale biomedizinische Unternehmen erfolgreich geleitet ...
Breaking Medicine Technology:AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 2AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 3Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 2Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 3Sequent Medical beruft Mike Kleine in den Aufsichtsrat 2Sequent Medical beruft Mike Kleine in den Aufsichtsrat 3
... a wholly-owned subsidiary of Integrated BioPharma,Inc. (NASDAQ: ... of vaccines against HPV, anthrax and plague ... The,studies were conducted by the Fraunhofer USA ... Organization led by Dr.,Vidadi Yusibov, through which ...
... Profile and Excellent,Pharmacokinetic Properties -, RESEARCH TRIANGLE PARK, ... a clinical stage company developing and,commercializing innovative treatments ... top-line results from a Phase I,clinical trial of ... and anxiety. In this study, Tyrima was safe ...
Cached Medicine Technology:Integrated BioPharma's Proprietary Vaccine Technology Achieves,Strong Positive Results 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
250L...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Medicine Products: